# Drug-Drug Interaction of Cladribine and Pantoprazole in Multiple Sclerosis Subjects

> **NCT00938366** · PHASE1 · COMPLETED · sponsor: **Merck KGaA, Darmstadt, Germany** · enrollment: 18 (actual)

## Conditions studied

- Multiple Sclerosis

## Interventions

- **DRUG:** Cladribine
- **DRUG:** Pantoprazole

## Key facts

- **NCT ID:** NCT00938366
- **Lead sponsor:** Merck KGaA, Darmstadt, Germany
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-01
- **Primary completion:** 2009-01
- **Final completion:** 2009-01
- **Target enrollment:** 18 (ACTUAL)
- **Last updated:** 2016-04-14

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00938366

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00938366, "Drug-Drug Interaction of Cladribine and Pantoprazole in Multiple Sclerosis Subjects". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00938366. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*